Three-dimensional structure of poliovirus serotype 1 neutralizing determinants
- PMID: 2451757
- PMCID: PMC253228
- DOI: 10.1128/JVI.62.5.1781-1794.1988
Three-dimensional structure of poliovirus serotype 1 neutralizing determinants
Abstract
Antigenic mutants of poliovirus (Sabin strain, serotype 1) were isolated by the resistance of the virus to anti-Sabin neutralizing monoclonal antibodies. The amino acid replacements within the capsid protein sequence causing the altered antigenicity were identified for each of 63 isolates. The mutations cluster into distinct nonoverlapping peptide segments that group into three general immunological phenotypes on the basis of cross-neutralization analyses with 15 neutralizing anti-Sabin monoclonal antibodies. Location of the mutated amino acid residues within the three-dimensional structure of the virion indicates that the majority of these amino acid residues are highly exposed and located within prominent structural features of the viral surface. Those mutated amino acid residues that are less accessible to antibody interaction are often involved in hydrogen bonds or salt bridges that would stabilize the local tertiary structure of the antigenic site. The interactions of the peptide segments that form these neutralizing sites suggest specific models for the generation of neutralization-resistant variants and for the interaction between the viral surface and antibody.
Similar articles
-
Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.J Virol. 1997 Sep;71(9):6905-12. doi: 10.1128/JVI.71.9.6905-6912.1997. J Virol. 1997. PMID: 9261417 Free PMC article.
-
Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.Virology. 1991 Sep;184(1):391-6. doi: 10.1016/0042-6822(91)90856-7. Virology. 1991. PMID: 1714663
-
Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.J Virol. 1986 Jan;57(1):81-90. doi: 10.1128/JVI.57.1.81-90.1986. J Virol. 1986. PMID: 2416957 Free PMC article.
-
[Molecular genetic analysis of poliovirus infection].Yakugaku Zasshi. 1989 Sep;109(9):622-35. doi: 10.1248/yakushi1947.109.9_622. Yakugaku Zasshi. 1989. PMID: 2481725 Review. Japanese.
-
The antigenic structure of poliovirus.Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12;323(1217):467-78. doi: 10.1098/rstb.1989.0024. Philos Trans R Soc Lond B Biol Sci. 1989. PMID: 2569204 Review.
Cited by
-
VIRO-TypeNed, systematic molecular surveillance of enteroviruses in the Netherlands between 2010 and 2014.Euro Surveill. 2016 Sep 29;21(39):30352. doi: 10.2807/1560-7917.ES.2016.21.39.30352. Euro Surveill. 2016. PMID: 27719752 Free PMC article.
-
A zebrafish coxsackievirus and adenovirus receptor homologue interacts with coxsackie B virus and adenovirus.J Virol. 2002 Oct;76(20):10503-6. doi: 10.1128/jvi.76.20.10503-10506.2002. J Virol. 2002. PMID: 12239327 Free PMC article.
-
Cryo-electron microscopy reconstruction shows poliovirus 135S particles poised for membrane interaction and RNA release.J Virol. 2014 Feb;88(3):1758-70. doi: 10.1128/JVI.01949-13. Epub 2013 Nov 20. J Virol. 2014. PMID: 24257617 Free PMC article.
-
Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.J Virol. 1993 Feb;67(2):1080-5. doi: 10.1128/JVI.67.2.1080-1085.1993. J Virol. 1993. PMID: 7678298 Free PMC article.
-
Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?Front Public Health. 2024 Jan 8;11:1284337. doi: 10.3389/fpubh.2023.1284337. eCollection 2023. Front Public Health. 2024. PMID: 38259741 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources